merus

merus

NASDAQ:MRUS

Chart

Detailed Quote

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Featured Articles and Interviews
back of man in yellow hard hat looking at oil refinery plant

How to Invest in Oil

How to Invest in Oil and Gas

How to Invest in Oil and Gas

Press Releases
The Conversation (0)